Bob Löwenberg, MD, PhD, assumed the role of editor-in-chief of Blood, the journal of the American Society of Hematology, in Washington, DC, in January. He succeeds Cynthia Dunbar, MD, head of the molecular hematopoiesis section of the National Heart, Lung, and Blood Institute.

Löwenberg is a professor of hematology at Erasmus University Medical School in Rotterdam, the Netherlands. He has published approximately 700 papers in leading scientific journals and has served on the editorial boards of several publications, including Blood, the New England Journal of Medicine, the Journal of Clinical Oncology, Leukemia, and the British Journal of Haematology. His research focuses on experimental hematology, stem cell transplantation, and the treatment and pathology of leukemia.

John C. Reed, MD, PhD, chief executive officer of Sanford-Burnham Medical Research Institute in La Jolla, CA, has been named head of Pharma Research and Early Development at Roche, based in Basel, Switzerland. He begins his new role on April 2. Kristiina Vuori, MD, PhD, Sanford-Burnham's president and director of its cancer center, will take over as chief executive on an interim basis.

Reed earned his medical and doctoral degrees at the University of Pennsylvania School of Medicine in Philadelphia. An internationally regarded biomedical scientist, he focuses his research on mechanisms that regulate apoptosis and how defects in apoptosis contribute to disease.

An author of several hundred research papers, Reed serves on the editorial board of several journals. Also, he holds more than 100 patents and has played a role in founding a number of biotechnology companies.

For more news on cancer research, visit Cancer Discovery online at http://CDnews.aacrjournals.org.